With LM3 and HepG2 orthotopic liver cancer models, the anti-cancer mechanism of CHOS was revealed by upregulating the NF-κB pathway, which promoted the expression of the p53 protein, leading to the apoptosis of cancer cells [119]. Here, TP53 is linked to cancer.